FBP1 was silenced using the small interfering RNA (siRNA) technique, and the effects on GBM cell proliferation, invasion, glucose metabolism, as well as the PI3K/AKT pathway and the BCL2/BAX protein family were comprehensively assessed. Here, FBP1 is linked to glioblastoma.